2026 Trends in Drug Benefit Design Report
PSG announces the results of its extensive research on the latest trends in drug benefit design. Plan sponsors face complex decisions and challenges…
Read Post
Insights
Categories
Topics
Categories
Topics
Value-Based Pharmaceutical Contracts: The Tool Few Payers Are Using — Why?
Value-based care and contracting is receiving substantial attention across the health care landscape as a tool for improving patient care and managing costs, and…
Read Post
The Buzz Around Weight Loss Drugs – What’s Driving It?
Who would have imagined one of the hottest online trends would be pharmaceuticals for weight loss? Social media and commercials are flooded with advertisements…
Read Post
PSG Releases Highly Anticipated ‘Trends in Specialty Drug Benefits Report’
(DALLAS, TX) – Pharmaceutical Strategies Group (PSG), an EPIC company, is pleased to announce the release of its annual Trends in Specialty Drug Benefits report. Delivering…
Read Post
Practical Strategies for Containing Pharmacy Costs
The pharmacy benefit management landscape is complex and ever-changing. With many new high-cost trending therapies currently available in addition to those on the horizon,…
Read Post
Claims Errors Adding Up? Let PSG Solve Your Math Problem
Key Metrics: 7% of PBM claims processed incorrectly $600K of reimbursement dollars due to client Background When a large government organization discovered that their…
Read Post
The Negotiation before the Negotiation: Medicare Drug Price Negotiation Program Initial Guidance
On March 15th the Centers for Medicare and Medicaid Services (CMS) released initial guidance on the Medicare Drug Price Negotiation Program (or “Negotiation…
Read Post
Looking for your perfect PBM? PSG has a knack for match making
Key Metrics: $5B amount saved by PSG’s RFP procurement clients in just one year. Background When planning their annual budget, a national retail employer…
Read Post
Amjevita, First Biosimilar of Humira, Launches With Two-Tiered Pricing Strategy
Republished with Permission from AIS Health More than six years after the FDA approved it, the first biosimilar of AbbVie…
Read Post
First Humira Biosimilar Hits the Market Today: Should We Be Excited?
Today is a milestone in the world of biosimilars, as the first Humira® biosimilar Amjevita™ (adalimumab-atto), manufactured by Amgen, has launched in the U.S. Will it…
Read Post
NEW PRODUCT LAUNCH: PSG Announces Artemetrx Extend
Revolutionary Drug Management Reporting Tool Offers Powerful User Insights Dallas, TX (January 23, 2023) – Artemetrx®, the industry’s most preeminent platform for integrated drug cost…
Read Post
2022 Pharmacy Benefit Manager Customer Satisfaction Report
Satisfaction is Shifting The most comprehensive research on PBM customer satisfaction. Overview here was a notable downturn in overall satisfaction…
Read Post